Airway Management for Critically Ill Children
(Pedi-PART Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best ways to help critically ill children breathe better during emergencies. Researchers are testing different strategies for EMS crews, such as using a bag-valve-mask (BVM), adding a supraglottic airway (SGA), or attempting endotracheal intubation (ETI) after BVM. The goal is to determine which method helps children survive without needing intensive care for 30 days. Children who have experienced a severe accident, heart or breathing failure, and require emergency care might be suitable for this study. Known as Prehospital Airway Resuscitation, or Pedi-PART, this study focuses on advanced airway management techniques. As an unphased trial, it offers a unique opportunity to contribute to life-saving research that could improve emergency care for children.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that these airway management strategies are safe for critically ill children?
Research has shown that various methods of assisting critically ill children with breathing are generally safe. For instance, emergency medical services (EMS) commonly and safely use a Bag-Valve-Mask (BVM) to help children breathe. Studies have found that following BVM with a Supraglottic Airway (SGA) is usually safe and effective.
Endotracheal Intubation (ETI), which involves placing a tube into the windpipe, is also widely used in emergencies. Although more invasive than other methods, trained EMS personnel routinely perform it. When done correctly, ETI is generally safe, though it may carry risks like discomfort or minor injury, which are usually manageable.
These methods have been trusted by professionals in critical situations for years. The trial aims to determine which method works best, but all are recognized as safe options.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores different airway management strategies for critically ill children, a crucial aspect of emergency care. Unlike traditional methods that might rely heavily on endotracheal intubation (ETI) from the start, this trial examines the effectiveness of using a Bag-Valve-Mask (BVM) first, followed by a Supraglottic Airway (SGA) or ETI. The BVM-only approach is also being studied to see if it offers comparable outcomes with less invasiveness. By comparing these methods, the trial aims to find the most effective and least invasive technique for managing airways in emergency situations, potentially improving outcomes and reducing complications for young patients.
What evidence suggests that this trial's airway management strategies could be effective for critically ill children?
This trial will compare different airway management strategies for critically ill children. Studies have shown that providing breathing support to critically ill children before they reach the hospital is crucial for their survival. In this trial, one group will use a Bag-Valve-Mask (BVM) only, while another group will use BVM followed by a Supraglottic Airway (SGA), a device placed above the voice box to secure breathing. A third group will use BVM followed by Endotracheal Intubation (ETI), which involves placing a tube directly into the windpipe. Both these additions aim to enhance breathing support compared to using a BVM alone. Initial findings suggest that selecting the optimal method can improve survival rates and reduce time in intensive care for children.12356
Who Is on the Research Team?
Henry E Wang, MD, MS
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for children under 18 who've had a cardiac arrest, major trauma, or respiratory failure and need emergency airway management. They must be at least 24 hours old and receive care from Pedi-PART EMS as part of an emergency response.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Stage I Treatment
EMS personnel alternate between BVM-only or BVM followed by SGA to determine better ICU-free survival
Stage II Treatment
EMS personnel alternate between the winner of Stage I and BVM followed by ETI to determine better ICU-free survival
Follow-up
Participants are monitored for ICU-free survival and neurologic outcomes up to 30 days after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Prehospital Airway Resuscitation
Prehospital Airway Resuscitation is already approved in United States for the following indications:
- Cardiopulmonary arrest
- Major trauma
- Respiratory failure
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
University of Utah
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator